Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medtor is a private U.S. medical device and health technology company developing patented optical sensing technology for clinical-grade vital signs monitoring in medical devices and consumer wearables. The company focuses on non-invasive oximetry and related physiological monitoring, with an emphasis on improving measurement accuracy during motion. Its offering appears to center on licensing intellectual property, supplying OEM technology, and supporting implementation for device manufacturers rather than developing therapeutics. Medtor markets a next-generation optical oximeter module and related IP for heart rate and blood oxygen monitoring applications. The business is best characterized as an active private digital health and medical device company rather than a biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medtor.